Literature DB >> 22038522

Common genetic variants differentially influence the transition from clinically defined states of fasting glucose metabolism.

G A Walford1, T Green, B Neale, T Isakova, J I Rotter, S F A Grant, C S Fox, J S Pankow, J G Wilson, J B Meigs, D S Siscovick, D W Bowden, M J Daly, J C Florez.   

Abstract

AIMS/HYPOTHESIS: Common genetic variants have been associated with type 2 diabetes. We hypothesised that a subset of these variants may have different effects on the transition from normal fasting glucose (NFG) to impaired fasting glucose (IFG) than on that from IFG to diabetes.
METHODS: We identified 16 type 2 diabetes risk variants from the Illumina Broad Candidate-gene Association Resource (CARe) array genotyped in 26,576 CARe participants. Participants were categorised at baseline as NFG, IFG or type 2 diabetic (n = 16,465, 8,017 or 2,291, respectively). Using Cox proportional hazards and likelihood ratio tests (LRTs), we compared rates of progression by genotype for 4,909 (NFG to IFG) and 1,518 (IFG to type 2 diabetes) individuals, respectively. We then performed multinomial regression analyses at baseline, comparing the risk of assignment to the NFG, IFG or diabetes groups by genotype.
RESULTS: The rate of progression from NFG to IFG was significantly greater in participants carrying the risk allele at MTNR1B (p = 1 × 10(-4)), nominally greater at GCK and SLC30A8 (p < 0.05) and nominally smaller at IGF2BP2 (p = 0.01) than the rate of progression from IFG to diabetes by the LRT. Results of the baseline, multinomial regression model were consistent with these findings. CONCLUSIONS/
INTERPRETATION: Common genetic risk variants at GCK, SLC30A8, IGF2BP2 and MTNR1B influence to different extents the development of IFG and the transition from IFG to type 2 diabetes. Our findings may have implications for understanding the genetic contribution of these variants to the development of IFG and type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22038522      PMCID: PMC3589986          DOI: 10.1007/s00125-011-2353-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  33 in total

Review 1.  Impaired fasting glucose and impaired glucose tolerance: implications for care.

Authors:  David M Nathan; Mayer B Davidson; Ralph A DeFronzo; Robert J Heine; Robert R Henry; Richard Pratley; Bernard Zinman
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

2.  Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps.

Authors:  M J Groenewoud; J M Dekker; A Fritsche; E Reiling; G Nijpels; R J Heine; J A Maassen; F Machicao; S A Schäfer; H U Häring; L M 't Hart; T W van Haeften
Journal:  Diabetologia       Date:  2008-07-11       Impact factor: 10.122

3.  Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study.

Authors:  J B Meigs; D M Nathan; P W Wilson; L A Cupples; D E Singer
Journal:  Ann Intern Med       Date:  1998-04-01       Impact factor: 25.391

4.  Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

Authors:  Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

5.  Increase in fasting insulin and glucose over seven years with increasing weight and inactivity of young adults. The CARDIA Study. Coronary Artery Risk Development in Young Adults.

Authors:  A R Folsom; D R Jacobs; L E Wagenknecht; S P Winkhart; C Yunis; J E Hilner; P J Savage; D E Smith; J M Flack
Journal:  Am J Epidemiol       Date:  1996-08-01       Impact factor: 4.897

6.  Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study.

Authors:  Martine Vaxillaire; Jacques Veslot; Christian Dina; Christine Proença; Stéphane Cauchi; Guillaume Charpentier; Jean Tichet; Frédéric Fumeron; Michel Marre; David Meyre; Beverley Balkau; Philippe Froguel
Journal:  Diabetes       Date:  2007-10-31       Impact factor: 9.461

7.  Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.

Authors:  Eleftheria Zeggini; Michael N Weedon; Cecilia M Lindgren; Timothy M Frayling; Katherine S Elliott; Hana Lango; Nicholas J Timpson; John R B Perry; Nigel W Rayner; Rachel M Freathy; Jeffrey C Barrett; Beverley Shields; Andrew P Morris; Sian Ellard; Christopher J Groves; Lorna W Harries; Jonathan L Marchini; Katharine R Owen; Beatrice Knight; Lon R Cardon; Mark Walker; Graham A Hitman; Andrew D Morris; Alex S F Doney; Mark I McCarthy; Andrew T Hattersley
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

8.  Common variants in WFS1 confer risk of type 2 diabetes.

Authors:  Manjinder S Sandhu; Michael N Weedon; Katherine A Fawcett; Jon Wasson; Sally L Debenham; Allan Daly; Hana Lango; Timothy M Frayling; Rosalind J Neumann; Richard Sherva; Ilana Blech; Paul D Pharoah; Colin N A Palmer; Charlotte Kimber; Roger Tavendale; Andrew D Morris; Mark I McCarthy; Mark Walker; Graham Hitman; Benjamin Glaser; M Alan Permutt; Andrew T Hattersley; Nicholas J Wareham; Inês Barroso
Journal:  Nat Genet       Date:  2007-07-01       Impact factor: 38.330

9.  Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies.

Authors:  Brendan J Keating; Sam Tischfield; Sarah S Murray; Tushar Bhangale; Thomas S Price; Joseph T Glessner; Luana Galver; Jeffrey C Barrett; Struan F A Grant; Deborah N Farlow; Hareesh R Chandrupatla; Mark Hansen; Saad Ajmal; George J Papanicolaou; Yiran Guo; Mingyao Li; Stephanie Derohannessian; Paul I W de Bakker; Swneke D Bailey; Alexandre Montpetit; Andrew C Edmondson; Kent Taylor; Xiaowu Gai; Susanna S Wang; Myriam Fornage; Tamim Shaikh; Leif Groop; Michael Boehnke; Alistair S Hall; Andrew T Hattersley; Edward Frackelton; Nick Patterson; Charleston W K Chiang; Cecelia E Kim; Richard R Fabsitz; Willem Ouwehand; Alkes L Price; Patricia Munroe; Mark Caulfield; Thomas Drake; Eric Boerwinkle; David Reich; A Stephen Whitehead; Thomas P Cappola; Nilesh J Samani; A Jake Lusis; Eric Schadt; James G Wilson; Wolfgang Koenig; Mark I McCarthy; Sekar Kathiresan; Stacey B Gabriel; Hakon Hakonarson; Sonia S Anand; Muredach Reilly; James C Engert; Deborah A Nickerson; Daniel J Rader; Joel N Hirschhorn; Garret A Fitzgerald
Journal:  PLoS One       Date:  2008-10-31       Impact factor: 3.240

10.  Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population.

Authors:  Ying Wu; Huaixing Li; Ruth J F Loos; Zhijie Yu; Xingwang Ye; Lihua Chen; An Pan; Frank B Hu; Xu Lin
Journal:  Diabetes       Date:  2008-07-15       Impact factor: 9.461

View more
  19 in total

1.  Common type 2 diabetes risk variant in MTNR1B worsens the deleterious effect of melatonin on glucose tolerance in humans.

Authors:  Marta Garaulet; Purificación Gómez-Abellán; Patricia Rubio-Sastre; Juan A Madrid; Richa Saxena; Frank A J L Scheer
Journal:  Metabolism       Date:  2015-08-14       Impact factor: 8.694

Review 2.  Insights into the genetic susceptibility to type 2 diabetes from genome-wide association studies of glycaemic traits.

Authors:  Letizia Marullo; Julia S El-Sayed Moustafa; Inga Prokopenko
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 3.  Minireview: Toward the establishment of a link between melatonin and glucose homeostasis: association of melatonin MT2 receptor variants with type 2 diabetes.

Authors:  Angeliki Karamitri; Nicolas Renault; Nathalie Clement; Jean-Luc Guillaume; Ralf Jockers
Journal:  Mol Endocrinol       Date:  2013-06-24

4.  Epidemiology and genetic determinants of progressive deterioration of glycaemia in American Indians: the Strong Heart Family Study.

Authors:  N Franceschini; K Haack; H H H Göring; V S Voruganti; S Laston; L Almasy; E T Lee; L G Best; R R Fabsitz; K E North; J W Maccluer; J B Meigs; J S Pankow; S A Cole
Journal:  Diabetologia       Date:  2013-07-14       Impact factor: 10.122

Review 5.  Tired of diabetes genetics? Circadian rhythms and diabetes: the MTNR1B story?

Authors:  Cecilia Nagorny; Valeriya Lyssenko
Journal:  Curr Diab Rep       Date:  2012-12       Impact factor: 4.810

Review 6.  Genetics of Type 2 Diabetes: It Matters From Which Parent We Inherit the Risk.

Authors:  Valeriya Lyssenko; Leif Groop; Rashmi B Prasad
Journal:  Rev Diabet Stud       Date:  2016-02-10

7.  Obesity and associated lifestyles modify the effect of glucose metabolism-related genetic variants on impaired glucose homeostasis among postmenopausal women.

Authors:  Su Yon Jung; Eric M Sobel; Jeanette C Papp; Carolyn J Crandall; Alan N Fu; Zuo-Feng Zhang
Journal:  Genet Epidemiol       Date:  2016-07-05       Impact factor: 2.135

Review 8.  Melatonin Effects on Glucose Metabolism: Time To Unlock the Controversy.

Authors:  Marta Garaulet; Jingyi Qian; Jose C Florez; Josephine Arendt; Richa Saxena; Frank A J L Scheer
Journal:  Trends Endocrinol Metab       Date:  2020-01-01       Impact factor: 12.015

Review 9.  Melatonin in type 2 diabetes mellitus and obesity.

Authors:  Angeliki Karamitri; Ralf Jockers
Journal:  Nat Rev Endocrinol       Date:  2019-02       Impact factor: 43.330

10.  Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.

Authors:  Folkert W Asselbergs; Yiran Guo; Erik P A van Iperen; Suthesh Sivapalaratnam; Vinicius Tragante; Matthew B Lanktree; Leslie A Lange; Berta Almoguera; Yolande E Appelman; John Barnard; Jens Baumert; Amber L Beitelshees; Tushar R Bhangale; Yii-Der Ida Chen; Tom R Gaunt; Yan Gong; Jemma C Hopewell; Toby Johnson; Marcus E Kleber; Taimour Y Langaee; Mingyao Li; Yun R Li; Kiang Liu; Caitrin W McDonough; Matthijs F L Meijs; Rita P S Middelberg; Kiran Musunuru; Christopher P Nelson; Jeffery R O'Connell; Sandosh Padmanabhan; James S Pankow; Nathan Pankratz; Suzanne Rafelt; Ramakrishnan Rajagopalan; Simon P R Romaine; Nicholas J Schork; Jonathan Shaffer; Haiqing Shen; Erin N Smith; Sam E Tischfield; Peter J van der Most; Jana V van Vliet-Ostaptchouk; Niek Verweij; Kelly A Volcik; Li Zhang; Kent R Bailey; Kristian M Bailey; Florianne Bauer; Jolanda M A Boer; Peter S Braund; Amber Burt; Paul R Burton; Sarah G Buxbaum; Wei Chen; Rhonda M Cooper-Dehoff; L Adrienne Cupples; Jonas S deJong; Christian Delles; David Duggan; Myriam Fornage; Clement E Furlong; Nicole Glazer; John G Gums; Claire Hastie; Michael V Holmes; Thomas Illig; Susan A Kirkland; Mika Kivimaki; Ronald Klein; Barbara E Klein; Charles Kooperberg; Kandice Kottke-Marchant; Meena Kumari; Andrea Z LaCroix; Laya Mallela; Gurunathan Murugesan; Jose Ordovas; Willem H Ouwehand; Wendy S Post; Richa Saxena; Hubert Scharnagl; Pamela J Schreiner; Tina Shah; Denis C Shields; Daichi Shimbo; Sathanur R Srinivasan; Ronald P Stolk; Daniel I Swerdlow; Herman A Taylor; Eric J Topol; Elina Toskala; Joost L van Pelt; Jessica van Setten; Salim Yusuf; John C Whittaker; A H Zwinderman; Sonia S Anand; Anthony J Balmforth; Gerald S Berenson; Connie R Bezzina; Bernhard O Boehm; Eric Boerwinkle; Juan P Casas; Mark J Caulfield; Robert Clarke; John M Connell; Karen J Cruickshanks; Karina W Davidson; Ian N M Day; Paul I W de Bakker; Pieter A Doevendans; Anna F Dominiczak; Alistair S Hall; Catharina A Hartman; Christian Hengstenberg; Hans L Hillege; Marten H Hofker; Steve E Humphries; Gail P Jarvik; Julie A Johnson; Bernhard M Kaess; Sekar Kathiresan; Wolfgang Koenig; Debbie A Lawlor; Winfried März; Olle Melander; Braxton D Mitchell; Grant W Montgomery; Patricia B Munroe; Sarah S Murray; Stephen J Newhouse; N Charlotte Onland-Moret; Neil Poulter; Bruce Psaty; Susan Redline; Stephen S Rich; Jerome I Rotter; Heribert Schunkert; Peter Sever; Alan R Shuldiner; Roy L Silverstein; Alice Stanton; Barbara Thorand; Mieke D Trip; Michael Y Tsai; Pim van der Harst; Ellen van der Schoot; Yvonne T van der Schouw; W M Monique Verschuren; Hugh Watkins; Arthur A M Wilde; Bruce H R Wolffenbuttel; John B Whitfield; G Kees Hovingh; Christie M Ballantyne; Cisca Wijmenga; Muredach P Reilly; Nicholas G Martin; James G Wilson; Daniel J Rader; Nilesh J Samani; Alex P Reiner; Robert A Hegele; John J P Kastelein; Aroon D Hingorani; Philippa J Talmud; Hakon Hakonarson; Clara C Elbers; Brendan J Keating; Fotios Drenos
Journal:  Am J Hum Genet       Date:  2012-10-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.